These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30303410)

  • 1. An analysis of the survival impact of dexmedetomidine in children undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Owusu-Agyemang P; Cata JP; Kapoor R; Zavala AM; Williams UU; Van Meter A; Tsai JY; Zhang WH; Feng L; Hayes-Jordan A
    Int J Hyperthermia; 2018; 35(1):435-440. PubMed ID: 30303410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the survival impact of perioperative opioid consumption in children and adolescents undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Owusu-Agyemang P; Hayes-Jordan A; Van Meter A; Williams UU; Zavala AM; Kapoor R; Popovich SM; Rebello E; Feng L; Cata JP
    Paediatr Anaesth; 2017 Jun; 27(6):648-656. PubMed ID: 28419679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    van Eden WJ; Kok NF; Jóźwiak K; Lahaye ML; Beets GL; van Leerdam ME; Boot H; Aalbers AG
    Dis Colon Rectum; 2017 May; 60(5):477-487. PubMed ID: 28383447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intraoperative dexmedetomidine on renal function after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized, placebo-controlled trial.
    Song Y; Kim DH; Kwon TD; Han DW; Baik SH; Jung HH; Kim JY
    Int J Hyperthermia; 2019; 36(1):1-8. PubMed ID: 30354794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of the survival impact of multimodal anesthesia/analgesia technique in adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score matched analysis.
    Cata JP; Nguyen LT; Ifeanyi-Pillette IC; Van Meter A; Dangler LA; Feng L; Owusu-Agyemang P
    Int J Hyperthermia; 2019; 36(1):369-375. PubMed ID: 30829082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
    Ihemelandu C; Mavros MN; Sugarbaker P
    Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
    Paul BK; Ihemelandu C; Sugarbaker PH
    Dis Colon Rectum; 2018 Mar; 61(3):347-354. PubMed ID: 29420428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Mehta A; Mittal R; Chandrakumaran K; Carr N; Dayal S; Mohamed F; Moran B; Cecil T
    Dis Colon Rectum; 2017 Nov; 60(11):1155-1161. PubMed ID: 28991079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma.
    Aziz O; Jaradat I; Chakrabarty B; Selvasekar CR; Fulford PE; Saunders MP; Renehan AG; Wilson MS; O'Dwyer ST
    Dis Colon Rectum; 2018 Jul; 61(7):795-802. PubMed ID: 29771808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Elderly Patients: Complete Cytoreduction Is Feasible and Crucial for Improved Survival Despite High Carcinomatosis Index.
    Naffouje SA; Salti GI
    Anticancer Res; 2018 Jan; 38(1):441-448. PubMed ID: 29277807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
    van Eden WJ; Kok NFM; Woensdregt K; Huitema ADR; Boot H; Aalbers AGJ
    Eur J Surg Oncol; 2018 Feb; 44(2):220-227. PubMed ID: 29258720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urological approach for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a clinical care center.
    Trujillo CG; Domínguez C; Robledo D; Caicedo JI; Bravo-Balado A; Cataño JG; Cortés N; Parra L; Riaño W; Londoño-Schimmer E; Otero J; Herrera G; Arias F; Plata M
    Acta Chir Belg; 2018 Dec; 118(6):348-353. PubMed ID: 29475412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis.
    Rihuete Caro C; Manzanedo I; Pereira F; Carrion-Alvarez L; Serrano Á; Pérez-Viejo E
    Eur J Surg Oncol; 2018 Nov; 44(11):1805-1810. PubMed ID: 30087071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?
    Baratti D; Kusamura S; Iusco D; Cotsoglou C; Guaglio M; Battaglia L; Virzì S; Mazzaferro V; Deraco M
    Dis Colon Rectum; 2018 Sep; 61(9):1026-1034. PubMed ID: 30086051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
    Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
    Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
    Canda AE; Arslan C; Terzi C; Sokmen S; Yavuzsen T; Ozkardesler S; Unlu M; Obuz F; Fuzun M
    World J Surg Oncol; 2018 Mar; 16(1):70. PubMed ID: 29587771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy at a tertiary care center: initial experience.
    Clemente-Gutiérrez U; Garza-Gangemi A; Trejo-Gómez G; Medina-Franco H
    Rev Invest Clin; 2015; 67(1):39-45. PubMed ID: 25857583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.
    Lee L; Alie-Cusson F; Dubé P; Sideris L
    J Surg Oncol; 2017 Aug; 116(2):236-243. PubMed ID: 28409831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial.
    Glockzin G; Zeman F; Croner RS; Königsrainer A; Pelz J; Ströhlein MA; Rau B; Arnold D; Koller M; Schlitt HJ; Piso P
    Clin Colorectal Cancer; 2018 Dec; 17(4):285-296. PubMed ID: 30131226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.